These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 3379198)

  • 1. Proarrhythmic effects of antiarrhythmic drugs in patients with malignant ventricular arrhythmias evaluated by electrophysiologic testing.
    Rae AP; Kay HR; Horowitz LN; Spielman SR; Greenspan AM
    J Am Coll Cardiol; 1988 Jul; 12(1):131-9. PubMed ID: 3379198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proarrhythmic responses during electrophysiologic testing.
    Horowitz LN; Greenspan AM; Rae AP; Kay HR; Spielman SR
    Am J Cardiol; 1987 Apr; 59(11):45E-48E. PubMed ID: 3578040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proarrhythmic effects of antiarrhythmic drugs during programmed ventricular stimulation in patients without ventricular tachycardia.
    Au PK; Bhandari AK; Bream R; Schreck D; Siddiqi R; Rahimtoola SH
    J Am Coll Cardiol; 1987 Feb; 9(2):389-97. PubMed ID: 2433319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous sustained ventricular tachyarrhythmias during treatment with type IA antiarrhythmic agents.
    Kudenchuk PJ; Kron J; Walance C; McAnulty JH
    Am J Cardiol; 1990 Feb; 65(7):446-52. PubMed ID: 2305683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiologic evaluation of antiarrhythmic therapy for ventricular tachyarrhythmias.
    Kuchar DL; Garan H; Ruskin JN
    Am J Cardiol; 1988 Oct; 62(12):39H-45H. PubMed ID: 3052008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic and antiarrhythmic efficacy of oral sotalol for sustained ventricular tachyarrhythmias: evaluation by programmed stimulation and ambulatory electrocardiogram.
    Steinbeck G; Bach P; Haberl R
    J Am Coll Cardiol; 1986 Oct; 8(4):949-58. PubMed ID: 3760368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aggravation of arrhythmia by antiarrhythmic drugs--incidence and predictors.
    Podrid PJ; Lampert S; Graboys TB; Blatt CM; Lown B
    Am J Cardiol; 1987 Apr; 59(11):38E-44E. PubMed ID: 2437788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reappraisal of criteria for assessing drug efficacy in patients with ventricular tachyarrhythmias: complete versus partial suppression of inducible arrhythmias.
    Borggrefe M; Trampisch HJ; Breithardt G
    J Am Coll Cardiol; 1988 Jul; 12(1):140-9. PubMed ID: 3379199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiologic and electrocardiographic effects, efficacy and safety of encainide in malignant ventricular arrhythmias associated with coronary artery disease.
    Weintraub AR; Manolis AS; Estes NA
    Am J Cardiol; 1990 Oct; 66(12):947-53. PubMed ID: 2121017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of the outcome of electrophysiologic study in patients with ventricular tachyarrhythmias.
    Schoenfeld MH; McGovern B; Garan H; Kelly E; Grant G; Ruskin JN
    J Am Coll Cardiol; 1985 Aug; 6(2):298-306. PubMed ID: 4019918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of the electrophysiology laboratory for evaluation of proarrhythmic drug response in coronary artery disease.
    Buxton AE; Rosenthal ME; Marchlinski FE; Miller JM; Flores B; Josephson ME
    Am J Cardiol; 1991 Apr; 67(9):835-42. PubMed ID: 1707220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiarrhythmic drug exacerbation of ventricular tachycardia inducibility during electrophysiologic study.
    Sager PT; Perlmutter RA; Rosenfeld LE; Batsford WP
    Am Heart J; 1992 Apr; 123(4 Pt 1):926-33. PubMed ID: 1550002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of nonsustained ventricular tachycardia as a guide to antiarrhythmic drug therapy in patients with malignant ventricular arrhythmia.
    Podrid PJ; Schoeneberger A; Lown B; Lampert S; Matos J; Porterfield J; Raeder E; Corrigan E
    Am Heart J; 1983 Feb; 105(2):181-8. PubMed ID: 6823797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic drug testing in patients with malignant ventricular arrhythmias: importance of stimulation at more than one ventricular site.
    Morady F; Hess D; Scheinman MM
    Am J Cardiol; 1982 Nov; 50(5):1055-60. PubMed ID: 7137032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with coronary artery disease as assessed by electrophysiologic studies.
    Rae AP; Greenspan AM; Spielman SR; Sokoloff NM; Webb CR; Kay HR; Horowitz LN
    Am J Cardiol; 1985 Jun; 55(13 Pt 1):1494-9. PubMed ID: 3890509
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiologic assessment of antiarrhythmic drug efficacy for ventricular tachyarrhythmias associated with dilated cardiomyopathy.
    Rae AP; Spielman SR; Kutalek SP; Kay HR; Horowitz LN
    Am J Cardiol; 1987 Feb; 59(4):291-5. PubMed ID: 3544793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitation of day to day variability in mode of induction of ventricular tachyarrhythmias by programmed stimulation.
    Cooper MJ; Hunt LJ; Palmer KJ; Denniss AR; Richards DA; Uther JB; Ross DL
    J Am Coll Cardiol; 1988 Jan; 11(1):101-8. PubMed ID: 3335686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proarrhythmic effects of antiarrhythmic drugs assessed by electrophysiologic study in recurrent sustained ventricular tachycardia.
    Chinushi M; Aizawa Y; Miyajima S; Funazaki T; Tamura M; Shibata A
    Jpn Circ J; 1991 Feb; 55(2):133-41. PubMed ID: 2020083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arrhythmogenic effects of antiarrhythmic drugs: a study of 506 patients treated for ventricular tachycardia or fibrillation.
    Stanton MS; Prystowsky EN; Fineberg NS; Miles WM; Zipes DP; Heger JJ
    J Am Coll Cardiol; 1989 Jul; 14(1):209-15; discussion 216-7. PubMed ID: 2738263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome in patients who survive out of hospital ventricular fibrillation and undergo electrophysiologic studies: evaluation by electrophysiologic subgroups.
    Poole JE; Mathisen TL; Kudenchuk PJ; McAnulty JH; Swerdlow CD; Bardy GH; Greene HL
    J Am Coll Cardiol; 1990 Sep; 16(3):657-65. PubMed ID: 2387939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.